Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells

Anna-Karine Bélizaire1, Lioudmila Tchistiakova, Yves St-Pierre

  • 1Supratek Pharma Inc. Laval, QC, Canada.

Insights

Researchers identified a novel peptide targeting intercellular adhesion molecule-1 (ICAM-1) on dysfunctional endothelial cells. This peptide, when part of a larger protein, can inhibit ICAM-1-mediated adhesion, offering potential for targeted therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Intercellular Adhesion Molecule-1 (ICAM-1) is expressed at low levels on healthy endothelial cells.
  • ICAM-1 is significantly upregulated in conditions like inflammation, cancer, and atherosclerosis, indicating cellular dysfunction.

Purpose of the Study:

  • To identify novel peptide sequences that specifically bind to the extracellular domain of murine ICAM-1 (mICAM-1).
  • To evaluate the potential of these peptides as targeting vectors for dysfunctional endothelium.
  • To assess the efficacy of a chimeric protein incorporating the peptide in inhibiting ICAM-1-mediated adhesion.

Main Methods:

  • Screening of a phage display library using COS-7 cells expressing mICAM-1 as a target.
  • Selection of clones via elution with a monoclonal antibody (mAb) specific for a functional ICAM-1 epitope.
  • Incorporation of the identified peptide into a chimeric protein and assessment of its inhibitory effect on ICAM-1-mediated adhesion.

Main Results:

  • A novel peptide sequence with binding affinity for the extracellular domain of mICAM-1 was identified.
  • The targeting specificity of the peptide was maintained when incorporated into a chimeric protein.
  • The chimeric protein demonstrated inhibition of ICAM-1-mediated intercellular adhesion during antigen presentation.

Conclusions:

  • The identified peptide serves as a potential targeting vector for dysfunctional endothelium.
  • Chimeric proteins incorporating this peptide can modulate ICAM-1-mediated cell-cell interactions.
  • These findings highlight the potential for developing targeted therapeutic agents for diseases involving adhesion molecules.

Related Concept Videos